Clinical Trials Browser

Brain Neoplasms × palbociclib × 30 days × Clear all

NCT02896335 2026-03-12

Palbociclib and Pembrolizumab In Central Nervous System Metastases

Phase 2 Recruiting

Brain Neoplasms